Company Kali, Inc.

KALY

US4833801016

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Market Closed - OTC Markets Other stock markets 09:30:00 2024-05-08 am EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2020	PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc..	CI
2020	PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc..	CI

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

Number of employees: 171

USD in Million	2017	Weight	2018	Weight	Delta
Pharmaceuticals 100.0 %	0	100.0 %	0	100.0 %	-3.44%

USD in Million	2017	Weight	2018	Weight	Delta
China 100.0 %	0	100.0 %	0	100.0 %	-3.44%

Managers	Title	Age	Since
Frederick Ferri CEO	Chief Executive Officer	-	18-12-18

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	285,133,954	282,282,614 ( 99.00 %)	0	98.86 %
Stock B	0	394,478	0	0

Kali, Inc.

8300 Douglas Avenue Suite 800

75225, Dallas

http://www.kali-extracts.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
KALI, INC.	0.00%	1.54K
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals